KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Inventory (2016 - 2020)

Historic Change in Inventory for Thermo Fisher Scientific (TMO) over the last 12 years, with Q4 2020 value amounting to $81.0 million.

  • Thermo Fisher Scientific's Change in Inventory rose 80000.0% to $81.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $508.0 million, marking a year-over-year increase of 1091.7%. This contributed to the annual value of $27.0 million for FY2024, which is 10451.51% up from last year.
  • According to the latest figures from Q4 2020, Thermo Fisher Scientific's Change in Inventory is $81.0 million, which was up 80000.0% from $118.0 million recorded in Q3 2020.
  • Thermo Fisher Scientific's 5-year Change in Inventory high stood at $176.0 million for Q3 2019, and its period low was -$127.0 million during Q4 2017.
  • Moreover, its 5-year median value for Change in Inventory was $76.0 million (2018), whereas its average is $63.6 million.
  • In the last 5 years, Thermo Fisher Scientific's Change in Inventory crashed by 19060.15% in 2016 and then skyrocketed by 80000.0% in 2020.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Change in Inventory stood at -$75.7 million in 2016, then plummeted by 67.77% to -$127.0 million in 2017, then skyrocketed by 92.91% to -$9.0 million in 2018, then surged by 200.0% to $9.0 million in 2019, then soared by 800.0% to $81.0 million in 2020.
  • Its last three reported values are $81.0 million in Q4 2020, $118.0 million for Q3 2020, and $168.0 million during Q2 2020.